RANDOMISED STUDY OF EPIDURAL VS MPCA MORPHINE VS TAPP IN LAPAROSCOPIC SIGMOIDECTOMY
NCT ID: NCT01825993
Last Updated: 2013-04-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
225 participants
INTERVENTIONAL
2013-04-30
2015-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Influence of Analgesic Technique on Post Operative Rehabilitation After Median Laparotomy
NCT04985695
Comparison of Epidural and TAP Block in Abdominal Surgery
NCT01848951
Transversus Abdominis Bilateral Plane Block in Total Laparoscopic Hysterectomy : A Randomized Controlled Trial
NCT01596660
Transversus Abdominis Plane (TAP) Block Using Liposomal Bupivacaine in Metabolic and Bariatric Surgery Patients
NCT05537883
Study in Subjects Undergoing Complete Abdominoplasty
NCT03789318
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PCA endovenous
1mg/10 min Morphine
MORPHINE
PERIDURAL CATHETER
Peridural L-bupivacaine 0.25%
L-BUPIVACAINE ; MORPHINE
TANSABDOMINAL BLOCK (TAP)
L-BUPIVACAINE im
L-BUPIVACAINE ; MORPHINE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
L-BUPIVACAINE ; MORPHINE
MORPHINE
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Laparoscopic sigmoidectomy
* Informed consent firmed
Exclusion Criteria
* Urgent surgery
* Sigmoid tumour stage IV
* Cronic pain treatment
* No informed consent firmed
* Paliative surgery
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Corporacion Parc Tauli
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
LAURA MORA LOPEZ
General Surgeon
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
PUJOL GEMMA, MD
Role: PRINCIPAL_INVESTIGATOR
Corporacion Parc Tauli
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Corporacion Parc Tauli
Sabadell, Sabadell-Barcelona, Spain
Corporacion Parc Tauli
Sabadell, Sabadell-barcelona, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
mora
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013-000556-17
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
CIR TAP 2013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.